Home / Share Price Target / Bacphar
Bacil Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Bacil Pharma Limited | |||
 | Symbol: BACPHAR | ||
| Price: ₹21.11 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Bacil Pharma Financial Performance
- 0.1.1: Is Bacil Pharma A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Bacil Pharma Share Price Target For 2024
- 1.1.1: Bacil Pharma Share Price Target Table For 2024
- 1.1.2: Summary: Bacil Pharma Share Price Prediction For 2024
- 1.2: Bacil Pharma Share Price Target For 2025
- 1.2.1: Bacil Pharma Share Price Target Table For 2025
- 1.2.2: Summary: Bacil Pharma Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Bacil Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Bacil Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Bacil Pharma Past Performance
Advertisement
Bacil Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 12.19 Crore | Market valuation of Bacil Pharma's shares. |
| Net Income (TTM) | -5.91 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
Is Bacil Pharma A Good Buy For Long Term?
Bacil Pharma's performance over the past few years, particularly its 347.24% return in the last three years and a whopping 817.82% return over the past five years, is undeniably impressive. However, recent performance has been more volatile, with a -21.18% return in the last three months. While the company's long-term potential remains promising, this recent volatility suggests investors should proceed with caution. It's a good idea to do further research into the company's fundamentals and future prospects before making a long-term investment decision.
To predict the Bacil Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Bacil Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Bacil Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bacil Pharma shares in 2024, see the table below.
Advertisement
Bacil Pharma Share Price Target Table For 2024
| Bacil Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 22.61 (+7.1%) | Price Action: Chart |
| 2024 Target 2 | 22.19 (+5.11%) | Price Action: Chart |
| 2024 Target 1 | 21.97 (+4.07%) | Fibonacci Extension Level 123.6% |
| Current Price | 21.11 | Bacil Pharma's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 20.81 (-1.43%) | Price Action: 05 Aug 2024 High |
| Stop Loss 2 | 20.30 (-3.84%) | Price Action: 04 Sep 2024 High |
| Stop Loss 3 | 19.91 (-5.69%) | Price Action: 03 Sep 2024 High |
Summary: Bacil Pharma Share Price Prediction For 2024
In summary, Bacil Pharma has surged by ₹14.73, achieving a notable +230.88% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Bacil Pharma for 2024 predicts an additional rise of 4.07% to 7.1% by the end of 2024 with three potential targets T1: 21.97, T2: 22.19, T3: 22.61. Stop Loss at SL1: 20.81, SL2: 20.30, SL3: 19.91.
Bacil Pharma has a 52-week high of ₹29.21, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4.71, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Bacil Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bacil Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Bacil Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bacil Pharma shares in 2025, see the table below.
Advertisement
Bacil Pharma Share Price Target Table For 2025
| Bacil Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 36.46 (+72.71%) | Price Action: Chart |
| 2025 Target 2 | 35.78 (+69.49%) | Price Action: Chart |
| 2025 Target 1 | 35.43 (+67.83%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 21.11 | Bacil Pharma's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 17.67 (-16.3%) | Price Action: 16 Aug 2024 High |
| Stop Loss 2 | 17.49 (-17.15%) | Price Action: Chart |
| Stop Loss 3 | 17.18 (-18.62%) | Price Action: Chart |
Summary: Bacil Pharma Share Price Prediction For 2025
In summary, Bacil Pharma has surged by ₹14.73, achieving a notable +230.88% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Bacil Pharma for 2025 predicts an additional rise of 67.83% to 72.71% by the end of 2025 with three potential targets T1: 35.43, T2: 35.78, T3: 36.46. Stop Loss at SL1: 17.67, SL2: 17.49, SL3: 17.18.
Bacil Pharma has a All-Time high of ₹29.21, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4.71, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Bacil Pharma, we have created a specific page for that check here: Bacil Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Bacil Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Bacil Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 14.42% over the next 15 years.
For complete year by year Bacil Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Bacil Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Bacil Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹21.11 | [Current Price] |
| 2024 | ₹16.64 | -21.18% |
| 2025 | ₹20.14 | 21.09% |
| 2026 | ₹45.33 | 124.96% |
| 2027 | ₹51.29 | 13.14% |
| 2028 | ₹39.06 | -23.85% |
| 2029 | ₹45.44 | 16.33% |
| 2030 | ₹46.07 | 1.38% |
| 2031 | ₹91.7 | 99.04% |
| 2032 | ₹94.85 | 3.43% |
| 2033 | ₹67.42 | -28.92% |
| 2034 | ₹74.25 | 10.13% |
| 2035 | ₹71.98 | -3.06% |
| 2036 | ₹138.07 | 91.81% |
| 2037 | ₹138.4 | 0.23% |
| 2038 | ₹95.77 | -30.81% |
| 2039 | ₹109.73 | 14.57% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bacil Pharma Past Performance
- In 2000, Bacil Pharma opening price was ₹4
- As of Fri 06 Sep 2024 the price stands at ₹21.11.
- This represents a Compound Annual Growth Rate (CAGR) of 6.88%.
- In 24 years, an investment of 10,000 would have become ₹52,775.
As we wrap up, we hope you like our study on Bacil Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
